The standard dosing schedule begins at 0.25 mg weekly for four weeks, then increases to 0.5 mg weekly, with potential escalation to 1 mg or 2 mg weekly depending on glycaemic control and tolerability
The mechanism is straightforward: severe vomiting and diarrhea cause dehydration, which reduces blood flow to the kidneys
The same cohort followed survivors who started GLP-1 medications while on endocrine therapy and reported improved overall survival, with no increase in disease-free survival events
When a significant effect in the model was observed, planned two-group contrasts (Tukey Honest Significant Difference [HSD] method) were applied
Large studies have shown they also: Reduce the risk of heart attacks by about 20% Lower the chance of strokes Decrease heart failure hospitalizations Reduce overall cardiovascular death Some of these benefits happen independently of blood pressure changes, which means GLP-1 medications protect your heart through multiple pathways
Adapted mineral level: Tailored for the sterilised cats needs